Pharmacology of Heart Failure
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 4397
Special Issue Editors
2. 2nd Department of Cardiology and Angiology, Silesian Center for Heart Diseases, 41-800 Zabrze, Poland
Interests: heart failure; cardiovascular disease; biomarkers; pharmacological treatment; drug interactions; risk stratification; prognostic scales
Special Issues, Collections and Topics in MDPI journals
Interests: heart failure; heart transplantation; mechanical circulatory support; biomarkers; risk stratification; cardiovascular disease; interventional therapy; device therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite advances in the prevention and treatment of cardiovascular diseases, heart failure remains a major challenge in developed countries, and its economic and social burden is still increasing. Over the years, many pharmacological and interventional treatments for heart failure have been developed that have improved the quality of life and global life expectancy. This has contributed to the need for more complex treatment regimens in heart failure, which is further complicated by the increasing age and high levels of comorbidity inherent in this patient group. Furthermore, a number of medications that are commonly used in clinical practice are relatively or absolutely contraindicated in patients with heart failure because they can cause exacerbations to this condition or have significant pharmacodynamic interactions with basic heart failure medications. This requires a holistic assessment of the patient and the meticulous management of medication regimens that are often complex.
Our aim for this Special Issue is to offer our readers short but comprehensive, state-of-the-art articles on the treatment of heart failure with regard to the pharmacokinetics and pharmacodynamics of drugs, drug interactions, adverse effects, and complex treatment regimens for comorbidities in heart failure.
Dr. Wioletta Szczurek-Wasilewicz
Prof. Dr. Bożena Szyguła-Jurkiewicz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- pharmacological treatment
- drug interactions
- side effect
- comorbidities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
